Insulin and insulin-like growth factor-I receptors in astrocytes exert different effects on behavior and Alzheimer´s-like pathology.
Jonathan Adrián Zegarra-ValdiviaAna M FernandezLaura Martinez-RachadellRaquel Herrero-LabradorJansen FernandesIgnacio Torres AlemanPublished in: F1000Research (2022)
Background: Pleiotropic actions of insulin and insulin-like growth factor I (IGF-I) in the brain are context- and cell-dependent, but whether this holds for their receptors (insulin receptor (IR) and IGF-I receptor (IGF-IR), respectively), is less clear. Methods: We compared mice lacking IR or IGF-IR in glial fibrillary astrocytic protein (GFAP)-expressing astrocytes in a tamoxifen-regulated manner, to clarify their role in this type of glial cells, as the majority of data of their actions in brain have been obtained in neurons. Results: We observed that mice lacking IR in GFAP astrocytes (GFAP IR KO mice) develop mood disturbances and maintained intact cognition, while at the same time show greater pathology when cross-bred with APP/PS1 mice, a model of familial Alzheimer´s disease (AD). Conversely, mice lacking IGF-IR in GFAP astrocytes (GFAP-IGF-IR KO mice) show cognitive disturbances, maintained mood tone, and show control-dependent changes in AD-like pathology. Conclusions: These observations confirm that the role of IR and IGF-IR in the brain is cell-specific and context-dependent.
Keyphrases
- binding protein
- high fat diet induced
- growth hormone
- type diabetes
- pi k akt
- white matter
- bipolar disorder
- metabolic syndrome
- cognitive decline
- oxidative stress
- stem cells
- single cell
- signaling pathway
- multiple sclerosis
- cell death
- sleep quality
- machine learning
- physical activity
- artificial intelligence
- depressive symptoms
- cell proliferation
- transcription factor
- electronic health record
- cell cycle arrest
- cerebral ischemia
- big data
- weight loss
- estrogen receptor
- mild cognitive impairment
- blood brain barrier